This suggests that even if the cytotoxic effect of chemotherapy provides a similar reduction effect on the tumor, other factors beyond cytotoxicity contribute to the durable effect of chemotherapy, which may be associated with increased tumor-specific immunity, represented by high circulating PD-1+CD8+ T cells levels on day 7. This evidence concerns the gene CD8A and neoplasm.